PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9694586-5 1998 This procedure, supplemented with deproteinization and reduction of nitrates to nitrites in the presence of NADPH-sensitive reductase, can be successfully applied for measurement of NOx levels in human body fluids (serum, urine and CSF). Nitrates 68-76 colony stimulating factor 2 Homo sapiens 232-235 11552025-2 2001 The levels of nitrite + nitrate (NOx) in CSF were fourfold higher in patients with PPMS than in controls (p < 0.001), whereas the concentrations in plasma were similar. Nitrates 24-31 colony stimulating factor 2 Homo sapiens 41-44 11556575-1 2001 Nitrate levels in CSF and sera from 16 coma and 19 noncoma falciparum malaria patients were determined using nitric oxide colorometric assay. Nitrates 0-7 colony stimulating factor 2 Homo sapiens 18-21 11556575-3 2001 The medians of nitrate level in CSF of coma and noncoma cases were 0.09 (0.01, 0.28) and 0.15 (0, 1.18) microM, respectively. Nitrates 15-22 colony stimulating factor 2 Homo sapiens 32-35 10203321-1 1999 To elucidate the involvement of NO in pain transmission in humans, we measured NO metabolites (nitrite/nitrate) in the CSF of patients with painful diseases using an NO analyzer based on the Griess method. Nitrates 103-110 colony stimulating factor 2 Homo sapiens 119-122 15050440-1 2004 The findings of various studies reporting temporal changes in CSF total nitrite/nitrate (NOx) levels after subarachnoid hemorrhage (SAH) vary considerably. Nitrates 80-87 colony stimulating factor 2 Homo sapiens 62-65 9411502-4 1997 The mean +/- levels of nitrite and nitrate in CSF on admission were higher in patients with BM in comparison with controls and in children with viral meningitis. Nitrates 35-42 colony stimulating factor 2 Homo sapiens 46-49 8741130-2 1996 Recently, it has been reported decreased CSF nitrate levels (oxidation product that provides an indirect estimation of nitric oxide) in Parkinson"s disease patients, assessed with a colorimetric method. Nitrates 45-52 colony stimulating factor 2 Homo sapiens 41-44 8741130-5 1996 They were not influenced significantly by antiparkinsonian drugs in patients, although there was a trend for CSF nitrate levels to be higher in patients treated with levodopa or with dopamine agonists. Nitrates 113-120 colony stimulating factor 2 Homo sapiens 109-112 9532589-5 1998 Nitrate and nitrite, were raised in the CSF and serum of patients with multiple sclerosis and other inflammatory neurological diseases compared to patients with non-inflammatory neurological disorders (median nitrate and nitrite: cerebrospinal fluid = 10.3 microM vs 15.4 microM vs 6.6 microM, P < 0.001, and serum = 49.0 microM vs 46.4 microM vs 38.8 microM, P = 0.02, respectively). Nitrates 0-7 colony stimulating factor 2 Homo sapiens 40-43 9532589-6 1998 CSF nitrate and nitrite levels correlated with the albumin quotient (n = 59, r = 0.42, P < 0.001). Nitrates 4-11 colony stimulating factor 2 Homo sapiens 0-3 9010412-0 1997 A rostrocaudal gradient of nitrate plus nitrite concentrations in CSF. Nitrates 27-34 colony stimulating factor 2 Homo sapiens 66-69 34940921-10 2022 There was an increase in nitrate levels of CSF and CSF/plasma ratio of nitrate in patients with PD and LID compared to the healthy controls. Nitrates 25-32 colony stimulating factor 2 Homo sapiens 43-46 34940921-10 2022 There was an increase in nitrate levels of CSF and CSF/plasma ratio of nitrate in patients with PD and LID compared to the healthy controls. Nitrates 71-78 colony stimulating factor 2 Homo sapiens 51-54 21450100-9 2011 CSF Nitrate levels were detected using the Griess reagent. Nitrates 4-11 colony stimulating factor 2 Homo sapiens 0-3